Form D - Notice of Exempt Offering of Securities:
SEC Accession No. 0001677077-17-000001
Filing Date
2017-08-22
Accepted
2017-08-22 16:57:18
Documents
1
Effectiveness Date
2017-08-22
Items
Item 06b:

Document Format Files

Seq Description Document Type Size
1 primary_doc.html D  
1 primary_doc.xml D 7852
  Complete submission text file 0001677077-17-000001.txt   8983
Mailing Address 50 W. BROADWAY 3RD FLOOR SALT LAKE CITY X1 84101
Business Address 50 W. BROADWAY 3RD FLOOR SALT LAKE CITY X1 84101 9493465822
Alzamend Neuro, Inc. (Filer) CIK: 0001677077 (see all company filings)

EIN.: 811822909 | State of Incorp.: DE | Fiscal Year End: 0430
Type: D | Act: 33 | File No.: 021-293300 | Film No.: 171045642
SIC: 2834 Pharmaceutical Preparations